关注
Jarosław Paluszczak
Jarosław Paluszczak
Poznan University of Medical Sciences, Department of Pharmaceutical Biochemistry
在 ump.edu.pl 的电子邮件经过验证
标题
引用次数
引用次数
年份
The Nrf2-ARE signaling pathway: An update on its regulation and possible role in cancer prevention and treatment
V Krajka-Kuźniak, J Paluszczak, W Baer-Dubowska
Pharmacological reports 69 (3), 393-402, 2017
2842017
The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells
J Paluszczak, V Krajka-Kuźniak, W Baer-Dubowska
Toxicology letters 192 (2), 119-125, 2010
2602010
Betanin, a beetroot component, induces nuclear factor erythroid-2-related factor 2-mediated expression of detoxifying/antioxidant enzymes in human liver cell lines
V Krajka-Kuźniak, J Paluszczak, H Szaefer, W Baer-Dubowska
British Journal of Nutrition 110 (12), 2138-2149, 2013
1492013
Pterostilbene is equally potent as resveratrol in inhibiting 12‐O‐tetradecanoylphorbol‐13‐acetate activated NFκB, AP‐1, COX‐2, and iNOS in mouse epidermis
M Cichocki, J Paluszczak, H Szaefer, A Piechowiak, AM Rimando, ...
Molecular nutrition & food research 52 (S1), S62-S70, 2008
1492008
Epigenetic diagnostics of cancer—the application of DNA methylation markers
J Paluszczak, W Baer-Dubowska
Journal of applied genetics 47, 365-375, 2006
1432006
Detection of MGMT, RASSF1A, p15INK4B, and p14ARF promoter methylation in circulating tumor-derived DNA of central nervous system cancer patients
A Majchrzak-Celińska, J Paluszczak, R Kleszcz, M Magiera, ...
Journal of applied genetics 54, 335-344, 2013
842013
The activation of the Nrf2/ARE pathway in HepG2 hepatoma cells by phytochemicals and subsequent modulation of phase II and antioxidant enzyme expression
V Krajka-Kuźniak, J Paluszczak, H Szaefer, W Baer-Dubowska
Journal of Physiology and Biochemistry 71, 227-238, 2015
762015
Frequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa
J Paluszczak, P Misiak, M Wierzbicka, A Woźniak, W Baer-Dubowska
Oral oncology 47 (2), 104-107, 2011
752011
The negative regulators of Wnt pathway—DACH1, DKK1, and WIF1 are methylated in oral and oropharyngeal cancer and WIF1 methylation predicts shorter …
J Paluszczak, J Sarbak, M Kostrzewska-Poczekaj, K Kiwerska, ...
Tumor Biology 36, 2855-2861, 2015
712015
Xanthohumol induces phase II enzymes via Nrf2 in human hepatocytes in vitro
V Krajka-Kuźniak, J Paluszczak, W Baer-Dubowska
Toxicology in Vitro 27 (1), 149-156, 2013
672013
Lichen-derived caperatic acid and physodic acid inhibit Wnt signaling in colorectal cancer cells
J Paluszczak, R Kleszcz, E Studzińska-Sroka, V Krajka-Kuźniak
Molecular and Cellular Biochemistry 441, 109-124, 2018
602018
Targeting aberrant cancer metabolism–The role of sirtuins
R Kleszcz, J Paluszczak, W Baer-Dubowska
Pharmacological Reports 67 (6), 1068-1080, 2015
582015
Prognostic significance of the methylation of Wnt pathway antagonists—CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling—ZIC1, ZIC4, and HHIP in head and neck …
J Paluszczak, D Wiśniewska, M Kostrzewska-Poczekaj, K Kiwerska, ...
Clinical Oral Investigations 21, 1777-1788, 2017
452017
Inhibition of CBP/β-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells
R Kleszcz, A Szymańska, V Krajka-Kuźniak, W Baer-Dubowska, ...
Cellular Oncology 42, 505-520, 2019
432019
The significance of the dysregulation of canonical Wnt signaling in head and neck squamous cell carcinomas
J Paluszczak
Cells 9 (3), 723, 2020
392020
Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas
J Paluszczak, D Hemmerling, M Kostrzewska‐Poczekaj, ...
Journal of oral pathology & medicine 43 (9), 652-657, 2014
292014
Phloretamide, an apple phenolic compound, activates the Nrf2/ARE pathway in human hepatocytes
V Krajka-Kuźniak, J Paluszczak, L Celewicz, J Barciszewski, ...
Food and Chemical Toxicology 51, 202-209, 2013
292013
Unknown face of known drugs–what else can we expect from angiotensin converting enzyme inhibitors?
A Wzgarda, R Kleszcz, M Prokop, K Regulska, M Regulski, J Paluszczak, ...
European journal of pharmacology 797, 9-19, 2017
282017
The methylation of a panel of genes differentiates low-grade from high-grade gliomas
A Majchrzak-Celińska, J Paluszczak, M Szalata, AM Barciszewska, ...
Tumor Biology 36, 3831-3841, 2015
282015
The inhibition of c-MYC transcription factor modulates the expression of glycolytic and glutaminolytic enzymes in FaDu hypopharyngeal carcinoma cells
R Kleszcz, J Paluszczak, V Krajka-Kuźniak, W Baer-Dubowska
Advances in Clinical and Experimental Medicine 27 (6), 735-742, 2018
272018
系统目前无法执行此操作,请稍后再试。
文章 1–20